Article
Mechanisms of drug resistance in hematologic malignancies.
Seminars in hematology - 1 Oct 1997
Dalton W S
Abstract excerpt
Multiple cellular mechanisms contribute to the overall clinical drug-resistant phenotype of malignant cells. A major mechanism of drug resistance documented to occur in hematologic malignancies is overexprssion of the MDR-1 gene product, P-glycoprotein (P-gp). Drugs, called chemosensitizers, have been designed to overcome P-gp-mediated drug resistance, and these agents are now being tested in the clinic....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
